GC
MBII

Guggenheim Capital’s Marrone Bio Innovations, Inc. MBII Stock Holding History

Guggenheim Capital’s Portfolio MBII Stock Details MBII Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-17,851
Closed -$36K – 2684
2018
Q1 		$36K Buy
+17,851
New +$23.9K ﹤0.01% 2719

Other funds holding MBII

AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
IAM
ICM Asset Management Spokane, Washington $18.1M AUM 30.29% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Guggenheim Capital's MBII Position: Q2 2018 in Review

Guggenheim Capital sold out of Marrone Bio Innovations, Inc. (MBII) in Q2 2018, closing a stake of 17,851 shares — an estimated $36K sold.

Guggenheim Capital first reported a position in MBII in Q1 2018 and held it in 1 quarter. The position peaked at $36K in Q1 2018. 44 funds tracked by Wall St. Rank hold MBII as of Q2 2018.

  • Guggenheim Capital reported no remaining Marrone Bio Innovations, Inc. position as of Q2 2018 after selling out during the quarter.
  • Guggenheim Capital sold 17,851 Marrone Bio Innovations, Inc. shares in Q2 2018, an estimated $36K.
  • Guggenheim Capital first reported a position in Marrone Bio Innovations, Inc. in Q1 2018 and held it in 1 quarter.
  • Guggenheim Capital's Marrone Bio Innovations, Inc. position peaked at $36K in Q1 2018.
  • 44 funds tracked by Wall St. Rank held Marrone Bio Innovations, Inc. as of Q2 2018.

Based on Guggenheim Capital's 13F filing for Q2 2018, filed 14 Aug 2018.